Coronial
NSWcommunity

Froio finding

Deceased

Francesco Froio

Date of death

2008-02-16

Finding date

2011-07-12

Cause of death

MDMA toxicity as a result of voluntarily ingesting that drug

AI-generated summary

Francesco Froio died at Liverpool Hospital on 16 February 2008 from MDMA toxicity following voluntary ingestion of the drug. The inquest (heard 7–9 March 2011) did not identify clinical failures but made administrative recommendations focused on improving drug-related death investigation procedures. The coroner recommended NSW Police amend their handbook to require consultation with the Officer in Charge and State Coroner Registry before destroying drug exhibits implicated in deaths. The NSW Department of Health was recommended to develop protocols for identifying and reporting unusual toxicology results, include drug composition and purity analysis in exhibits testing, and establish procedures for detecting paramethoxyamphetamine (PMA) in toxicology results. These recommendations aim to improve the chain of evidence and quality of forensic analysis in drug-related death investigations.

AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.

Drugs involved

Clinical conditions

Contributing factors

  • voluntary ingestion of MDMA

Coroner's recommendations

  1. NSW Police Force to amend the NSW Police Force Handbook regarding destruction of prohibited drugs to require consultation with the Officer in Charge of the investigation and the Registry of the Office of the NSW State Coroner before making any destruction order
  2. NSW Department of Health (Divisional of Analytical Laboratories and Department of Forensic Medicine) to draw up a protocol for identifying cases with unusual or unexpected toxicology results and ensuring such cases are drawn to the attention of the Officer in Charge of the Investigation and the Registry of the Office of the NSW State Coroner
  3. NSW Department of Health (Divisional of Analytical Laboratories and Department of Forensic Medicine) to ensure analysis of any relevant drug exhibits implicated in deaths includes the composition and purity of the drug where possible
  4. NSW Department of Health (Divisional of Analytical Laboratories and Department of Forensic Medicine) to develop procedures for identifying in toxicology results the presence of, and where detected the quantity of, paramethoxyamphetamine (PMA)
Full text

Source and disclaimer

This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.

Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.

Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —